ConductScience.org, home

Paper33733490

Significantly Improving the Bioefficacy for Rheumatoid Arthritis with Supramolecular Nanoformulations.

Ma C and 11 others. Adv Mater, 2021. Cited by 45 papers, by iCite.

Cite this record

ConductScience Library. Significantly Improving the Bioefficacy for Rheumatoid Arthritis with Supramolecular Nanoformulations. Papers, record 33733490. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33733490

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Significantly Improving the Bioefficacy for Rheumatoid Arthritis with Supramolecular Nanoformulations.
PubMed
Journal
Adv Mater
PubMed
Year
2021
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
45
iCite
Relative citation ratio, by iCite
2.69
iCite
Revised in PubMed
2024-07-24
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ma CChao
2Li BBo
3Zhang JJinrui
4Sun YYao
5Li JJingjing
6Zhou HHangcheng
7Shen JJianlei
8Gu RRui
9Qian JJiangchao
10Fan CChunhai
11Zhang HHongjie
12Liu KKaihttps://orcid.org/0000-0003-0878-5191

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Arthritis, RheumatoidMajor topic
Interleukin 1 Receptor Antagonist ProteinMajor topic
Animals
Rats
Humans
Nanoparticles
Biological Availability

Source PubMed

Download CSV of topics

Grants6

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
2020YFA0908900National Key R&D Program of ChinaPubMed
2018YFA0902600National Key R&D Program of ChinaPubMed
GJTD-2018-09National Key R&D Program of ChinaPubMed
21877104National Natural Science Foundation of ChinaPubMed
21834007National Natural Science Foundation of ChinaPubMed
22020102003National Natural Science Foundation of ChinaPubMed

Source PubMed

Download CSV of grants

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 45 citations.

PMIDTitleJournalYearIn PapersSource
42921895Spatiotemporally Precise Rheumatoid Arthritis Therapy via a Triple-Locked Cascaded Nanoplatform With Dual-Channel Self-Reporting.Adv Sci (Weinh)2026https://conductscience.org/library/papers/42921895PubMed
42563363Stimuli-Responsive Nanoplatforms for Precision Intervention in Rheumatoid Arthritis.Wiley Interdiscip Rev Nanomed Nanobiotechnol2026https://conductscience.org/library/papers/42563363PubMed
42325403Nanomedicine Strategies for Rheumatoid Arthritis: Precision Delivery and Immune Microenvironment Modulation.Int J Nanomedicine2026https://conductscience.org/library/papers/42325403PubMed
42253851Bio-Inspired and Protein-Based Elastomeric Materials.Polym Sci Technol2026https://conductscience.org/library/papers/42253851PubMed
41350407Bioengineered photosynthetic nanothylakoids reshape the inflammatory microenvironment for rheumatoid arthritis therapy.Nat Nanotechnol2026https://conductscience.org/library/papers/41350407PubMed
40727579Nanotechnology in Orthopedic Care: Advances in Drug Delivery, Implants, and Biocompatibility Considerations.Int J Nanomedicine2025https://conductscience.org/library/papers/40727579PubMed
40285644Composite Mapping for Peptide-Based Data Storage with Higher Coding Density and Fewer Synthesis Cycles.Adv Sci (Weinh)2025https://conductscience.org/library/papers/40285644PubMed
40088037Nanovaccine loaded with seno-antigen target senescent cells to improve metabolic disorders of adipose tissue and cardiac dysfunction.Hum Vaccin Immunother2025https://conductscience.org/library/papers/40088037PubMed
39985217Biomimetic Nanoplatform for Targeted Rheumatoid Arthritis Therapy: Modulating Macrophage Niches Through Self-Sustaining Positive Feedback-Driven Drug Release Mechanisms.Adv Sci (Weinh)2025https://conductscience.org/library/papers/39985217PubMed
38932929Highly reliable and efficient encoding systems for hexadecimal polypeptide-based data storage.Fundam Res2023https://conductscience.org/library/papers/38932929PubMed
37169742Applications of synthetic biology in medical and pharmaceutical fields.Signal Transduct Target Ther2023https://conductscience.org/library/papers/37169742PubMed
36632509Nanomaterial-assisted theranosis of bone diseases.Bioact Mater2023https://conductscience.org/library/papers/36632509PubMed
36092568Long-Lasting Proteinaceous Nanoformulation for Tumor Imaging and Therapy.ACS Omega2022https://conductscience.org/library/papers/36092568PubMed
35547753Mitochondria-targeted supramolecular coordination container encapsulated with exogenous itaconate for synergistic therapy of joint inflammation.Theranostics2022https://conductscience.org/library/papers/35547753PubMed
35415310Dimethylamino group modified polydopamine nanoparticles with positive charges to scavenge cell-free DNA for rheumatoid arthritis therapy.Bioact Mater2022https://conductscience.org/library/papers/35415310PubMed
35023331Inflammation-Triggered Supramolecular Nanoplatform for Local Dynamic Dependent Imaging-Guided Therapy of Rheumatoid Arthritis.Adv Sci (Weinh)2022https://conductscience.org/library/papers/35023331PubMed
35018745Highly Plasticized Lanthanide Luminescence for Information Storage and Encryption Applications.Adv Sci (Weinh)2022https://conductscience.org/library/papers/35018745PubMed
34876139Acupoint nanocomposite hydrogel for simulation of acupuncture and targeted delivery of triptolide against rheumatoid arthritis.J Nanobiotechnology2021https://conductscience.org/library/papers/34876139PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
IL1RN3557PubTator's text mininghttps://conductscience.org/library/genes/3557

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33733490

GET https://conductscience.org/api/papers/v1/33733490/authors